ISRCTN28134901
Completed
未知
Idiopathic pulmonary fibrosis with or without emphysema: a 3-year multi-centre study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Taichung Veterans General Hospital
- Enrollment
- 275
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with a definitive diagnosis of interstitial lung disease by a pulmonologist and confirmed by high\-resolution computed tomography (HRCT)
- •2\. Passed the health insurance review to pay for the anti\-pulmonary fibrosis medications
Exclusion Criteria
- •1\. Patients not fulfilling the criteria of interstitial lung disease
- •2\. Patients not having health insurance to cover anti\-fibrotic medications
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 2
Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)Idiopathic Pulmonary FibrosisNCT01504334Beijing Kawin Technology Share-Holding Co., Ltd.80
Unknown
Not Applicable
Characteristics and Health Related Quality of Life in Idiopathic Pulmonary FibrosisIdiopathic Pulmonary FibrosisNCT03171870Assiut University1
Terminated
Phase 2
A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPFPersistent Cough in IPFChronic CoughIPFNCT03864328Respivant Sciences GmbH108
Completed
Phase 3
Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis CoughIdiopathic Pulmonary FibrosisNCT04429516Royal Brompton & Harefield NHS Foundation Trust44
Recruiting
Not Applicable
Idiopathic Pulmonary Fibrosis treated with Anti-fibrotic Drugs Prospective Observational TrialIdiopathic pulmonary fibrosisJPRN-UMIN000019826HO Kinki-Chuo Chest Medical Center100